The FDA announced a June advisory committee meeting about COVID vaccines for kids younger than 6. The AMA has updated its billing codes ahead of an expected decision on Moderna s shot in this age group
Moderna s chief medical officer said on Sunday the company s vaccine for children under 6 years old will be ready for review by a Food and Drug Administration panel when it meets in June.
The FDA s independent panel of advisors will meet in June to discuss the Pfizer and Moderna COVID-19 vaccines for children under age 5, as well as the Novavax vaccine for adults.
India has approved emergency use of Biological E s COVID-19 vaccine Corbevax for children aged five to 12 and Bharat Biotech s Covaxin inactivated-virus vaccine for six to 12-year-olds, the country s health minister said on Tuesday.